2nd Circuit Affirms Taxing Zometa Plaintiff For Costs, Denies Attorney Sanctions

NEW YORK - A Second Circuit U.S. Court of Appeals panel on Dec. 17 affirmed the personal taxation of $5,528 in litigation costs against a widow who lost the first federal Zometa jaw injury trial but denied defendant Novartis Pharmaceutical Corp.'s motion to sanction the woman's attorney for misrepresenting that she was a proper representative of her husband's estate (Karlene Hogan v. Novartis Pharmaceuticals Corporation, No. 12-5085, 2nd Cir.).

Access this news story on lexis.com®